Form 4 for IRWD IRONWOOD PHARMACEUTICALS INC
Accepted 2022-08-17 00:00:00 ET · period of report 2022-08-15 · accession 0001209191-22-046225 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-08-17 | 2022-08-15 | IRWD | Silver Ronald | Principal Accounting Off | S - Sale | $11.77 | -2,014 | 105.2K | -2% | -$23.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-08-15 | S | D | 2,014 | $11.77 | 105,151 | D | — | — | (F2) The reporting person acquired 2,092 shares of Class A Common Stock under the issuer's employee stock purchase plan on June 30, 2022. |